ATP2A2 and Huntington disease: Certainly the work we have presented has several limitations such as to validate the results obtained on a different cohort of patients and investigate the possible pathogenetic significance of the reduction of SERCA2 and VEGF mRNAs both in peripheral tissues and the central nervous system of HD patients.